1,152
Participants
Start Date
September 30, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Calcipotriol plus betamethasone
Topical suspension once daily for up to 8 weeks.
Betamethasone-17,21-dipropionate
Topical suspension once daily for up to 8 weeks.
Calcipotriene
Topical suspension once daily for up to 8 weeks.
Topical suspension vehicle
Topical suspension once daily for up to 8 weeks.
Mount Sinai School of Medicine, New York
Derm Research Center of New York, Stony Brook
University of Pittsburgh Medical Center, Pittsburgh
King-Maceyko Dermatology Associates, Johnstown
Lawrence J. Green, MD, LLC, Rockville
Triangle Medical Research Associates, LLC, Cary
Atlanta Dermatology, Vein & Research Center, Alpharetta
Gwinnett Clinical Research Center, Inc, Snellville
Peachtree Dermatology Associates, Atlanta
Dermatologic Surgery Specialists, PC, Macon
Ameriderm Research, Ormond Beach
North Florida Dermatology Associates, PA, Jacksonville
Dermatology Associates and Research, Coral Gables
International Dermatology Research, Inc., Miami
Palm Beach Research Center, West Palm Beach
Visions Clinical Research, Boynton Beach
Horizon Research Group, Inc, Mobile
Dermatology Specialists, Louisville
Owensboro Dermatology Associates, Owensboro
Haber Dermatology and Cosmetic Surgery, South Euclid
Indiana Clinical Trials Center, Plainfield
Dawes Fretzin Clinical Research Group, Indianapolis
Deaconess Clinic, Inc., Evansville
Hudson Dermatology, Evansville
Michigan Center for Research Corp.,, Clinton Township
Hamzavi Dermatology, Fort Gratiot
Somerset Skin Centre, Troy
Grekin Skin Institute, Warren
David Fivenson, MD Dermatology, PLC, Ann Arbor
Henry Ford Health System, Detroit
Great Lakes Research Group, Inc, Bay City
Minnesota Clinical Study Center, Fridley
Altman Dermatology Associates, Arlington Hts
Glazer Dermatology, Buffalo Grove
Burke Pharmaceutical Research, Hot Springs
Division of Dermatology, Baylor Research Institute, Dallas
Centre for Clinical Studies, Houston
J&S Studies, Inc., College Station
Clinical Trials of Texas, Inc., San Antonio
Dermatology Clinical Research Center of San Antonio, San Antonio
Progressive Clinical Research, P.A., San Antonio
Colorado Medical Research Center, Inc., Denver
Horizons Clinical Research Center, LLC, Denver
Dermatology Research Center, Inc., Salt Lake City
Academic Dermatology Associates, Albuquerque
Karl G. Heine, M. D. Dermatology, Henderson
Clinical Science Institute, Santa Monica
Dermatology Research Centers, Santa Monica
DBA Torrance Clinical Research, Lomita
Dermatology Specialists, Inc., Oceanside
Skin Surgery Medical Group, Inc., San Diego
Walter Nahm, MD, Ph.D., Inc, San Diego
Advanced Clinical Research Institute, Anaheim
Coastal Medical Research Group, Inc., San Luis Obispo
Oregon Dermatology and Research Center, Portland
Premier Clinical Research, Spokane
Psoriasis Treatment Center of Central NJ, East Windsor
Anderson & Collins Clinical Research, Inc., Edison
The Dermatology Group, PC, Verona
Lead Sponsor
LEO Pharma
INDUSTRY